InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CHINA PHARMA HOLDINGS, INC.

CPHI Clue Score31
China Fiscal year ends December CIK 0001106644
$0.87 -9.32% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.87 +60.55% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue15.6Operating income−8.2Net income−9.2Fiscal year 2017Revenue13.2 −15.1%Operating income−18.7Net income−19.3Fiscal year 2018Revenue12.3 −6.7%Operating income−10.4Net income−10.8Fiscal year 2019Revenue10.9 −11.4%Operating income−20.4Net income−20.7Fiscal year 2020Revenue10.9 −0.5%Operating income−2.6Net income−2.9Fiscal year 2021Revenue9.6 −11.3%Operating income−2.9Net income−3.4EPS, diluted−0.74Fiscal year 2022Revenue8.1 −15.9%Operating income−3.5Net income−4.0EPS, diluted−3.78Fiscal year 2023Revenue7.0 −13.5%Operating income−2.8Net income−3.1EPS, diluted−0.91Fiscal year 2024Revenue4.5 −35.4%Operating income−4.6Net income−4.7EPS, diluted−2.71Fiscal year 2025Revenue4.1 −8.5%Operating income−3.2Net income−3.2EPS, diluted−0.74
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 15.6 13.2 12.3 10.9 10.9 9.6 8.1 7.0 4.5 4.1
Growth −15.1% −6.7% −11.4% −0.5% −11.3% −15.9% −13.5% −35.4% −8.5%
Operating income −8.2 −18.7 −10.4 −20.4 −2.6 −2.9 −3.5 −2.8 −4.6 −3.2
Net income −9.2 −19.3 −10.8 −20.7 −2.9 −3.4 −4.0 −3.1 −4.7 −3.2
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.74 −3.78 −0.91 −2.71 −0.74
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin20.7%Operating margin−52.4%Net margin−59.0%Free cash flow margin17.4%Fiscal year 2017Gross margin18.7%Operating margin−141.4%Net margin−145.9%Free cash flow margin5.3%Fiscal year 2018Gross margin16.0%Operating margin−84.7%Net margin−87.2%Free cash flow margin14.8%Fiscal year 2019Gross margin13.6%Operating margin−186.8%Net margin−189.5%Free cash flow margin4.3%Fiscal year 2020Gross margin18.0%Operating margin−23.7%Net margin−26.4%Free cash flow margin−8.4%Fiscal year 2021Gross margin3.6%Operating margin−29.7%Net margin−35.3%Free cash flow margin−7.1%Fiscal year 2022Gross margin−6.1%Operating margin−43.8%Net margin−49.0%Free cash flow margin−10.0%Fiscal year 2023Gross margin−4.0%Operating margin−39.2%Net margin−43.9%Free cash flow margin−10.1%Fiscal year 2024Gross margin−43.8%Operating margin−101.3%Net margin−104.6%Free cash flow margin−9.8%Fiscal year 2025Gross margin−3.2%Operating margin−78.2%Net margin−76.9%Free cash flow margin2.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 20.7% 18.7% 16.0% 13.6% 18.0% 3.6% −6.1% −4.0% −43.8% −3.2%
Operating margin −52.4% −141.4% −84.7% −186.8% −23.7% −29.7% −43.8% −39.2% −101.3% −78.2%
Net margin −59.0% −145.9% −87.2% −189.5% −26.4% −35.3% −49.0% −43.9% −104.6% −76.9%
Free cash flow margin 17.4% 5.3% 14.8% 4.3% −8.4% −7.1% −10.0% −10.1% −9.8% 2.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow2.9Capital expenditure−0.2Free cash flow2.7Fiscal year 2017Operating cash flow0.8Capital expenditure−0.1Free cash flow0.7 −73.9%Fiscal year 2018Operating cash flow1.9Capital expenditure−0.1Free cash flow1.8 +159.8%Fiscal year 2019Operating cash flow0.6Capital expenditure−0.1Free cash flow0.5 −74.2%Fiscal year 2020Operating cash flow−0.0Capital expenditure−0.9Free cash flow−0.9 −292.6%Fiscal year 2021Operating cash flow−0.2Capital expenditure−0.4Free cash flow−0.7Fiscal year 2022Operating cash flow−0.4Capital expenditure−0.4Free cash flow−0.8Fiscal year 2023Operating cash flow−0.7Capital expenditure−0.0Free cash flow−0.7Fiscal year 2024Operating cash flow−0.4Capital expenditure−0.0Free cash flow−0.4Fiscal year 2025Operating cash flow0.1Capital expenditure−0.1Free cash flow0.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 2.9 0.8 1.9 0.6 −0.0 −0.2 −0.4 −0.7 −0.4 0.1
Capital expenditure −0.2 −0.1 −0.1 −0.1 −0.9 −0.4 −0.4 −0.0 −0.0 −0.1
Free cash flow 2.7 0.7 1.8 0.5 −0.9 −0.7 −0.8 −0.7 −0.4 0.1
Growth −73.9% +159.8% −74.2% −292.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash2.7Shareholders’ equity58.9Fiscal year 2017Cash2.0Total debt9.2Net cash (debt)−7.2Shareholders’ equity43.1Debt to equity0.21Fiscal year 2018Cash1.2Total debt6.5Net cash (debt)−5.4Shareholders’ equity30.2Debt to equity0.22Fiscal year 2019Cash1.1Total debt4.3Net cash (debt)−3.2Shareholders’ equity9.2Debt to equity0.47Fiscal year 2020Cash1.0Total debt5.2Net cash (debt)−4.3Shareholders’ equity8.0Debt to equity0.65Fiscal year 2021Cash4.9Shareholders’ equity6.0Fiscal year 2022Cash2.0Shareholders’ equity4.3Fiscal year 2023Cash1.4Shareholders’ equity7.5Fiscal year 2024Cash0.6Shareholders’ equity7.7Fiscal year 2025Cash0.3Shareholders’ equity22.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.7 2.0 1.2 1.1 1.0 4.9 2.0 1.4 0.6 0.3
Total debt n/a 9.2 6.5 4.3 5.2 n/a n/a n/a n/a n/a
Net cash (debt) n/a −7.2 −5.4 −3.2 −4.3 n/a n/a n/a n/a n/a
Shareholders’ equity 58.9 43.1 30.2 9.2 8.0 6.0 4.3 7.5 7.7 22.7
Debt to equity n/a 0.21 0.22 0.47 0.65 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
15.6 13.2 12.3 10.9 10.9 9.6 8.1 7.0 4.5 4.1
Growth −15.1% −6.7% −11.4% −0.5% −11.3% −15.9% −13.5% −35.4% −8.5%
12.4 10.7 10.4 9.4 8.9 9.3 8.6 7.3 6.5 4.3
3.2 2.5 2.0 1.5 2.0 0.3 −0.5 −0.3 −2.0 −0.1
Growth −23.3% −20.0% −24.9% +31.8% −82.1% −241.4%
0.4 0.1 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.3
2.3 2.0 1.9 2.3 1.8 1.7 1.9 1.5 1.8 2.5
−8.2 −18.7 −10.4 −20.4 −2.6 −2.9 −3.5 −2.8 −4.6 −3.2
Growth
−8.9 −19.2 −10.9 −20.7 −2.9 −3.4 −4.0 −3.1 −4.7 −3.2
0.3 0.1 −0.1 n/a n/a n/a n/a n/a n/a n/a
−9.2 −19.3 −10.8 −20.7 −2.9 −3.4 −4.0 −3.1 −4.7 −3.2
Growth
Per share
n/a n/a n/a n/a n/a −0.74 −3.78 −0.91 −2.71 −0.74
n/a n/a n/a n/a n/a −0.74 −3.78 −0.91 −2.71 −0.74
Growth
n/a n/a n/a n/a n/a 4.6 1.1 3.4 1.7 4.3

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 17.5% a year over five years.
  • Operating margin is down 54.4 points on five years ago, at -78.2%.
  • A net loss in 10 of 10 years on file.